Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR/Cas9-mediated noncoding RNA editing in human cancers

13 Oct 2017

Abstract excerpt

Cancer is characterized by multiple genetic and epigenetic alterations, including a higher prevalence of mutations of oncogenes and/or tumor suppressors. Mounting evidences have shown that noncoding RNAs (ncRNAs) are involved in the epigenetic regulation of cancer genes and their associated pathways. The clustered regularly interspaced short palindromic repeats (CRISPR)-associated nuclease 9 (CRISPR/Cas9) system,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Cytomegalovirus and herpesvirus research
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29028415
DOI: 10.1080/15476286.2017.1391443

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9-mediated noncoding RNA editing in human cancersPMID 29028415Read ↗

Prospects and challenges of CRISPR /Cas9 gene‐editing technology in cancer researchSemantic proximity Read ↗

Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer ResearchSemantic proximity Read ↗

CRISPR/Cas9 in cancer: An attempt to the present trends and future prospects.Semantic proximity Read ↗

Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.Semantic proximity Read ↗

CRISPR/Cas9 for cancer treatment: technology, clinical applications and challengesSemantic proximity Read ↗

Strategies to overcome the main challenges of the use of CRISPR/Cas9 as a replacement for cancer therapy.Semantic proximity Read ↗

Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future ResearchSemantic proximity Read ↗

CRISPR/Cas9: an overview of recent developments and applications in cancer researchSemantic proximity Read ↗

Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and ChallengesSemantic proximity Read ↗

CRISPR/Cas9-Mediated Genome Editing in Cancer TherapySemantic proximity Read ↗

CRISPR/Cas9 technology in tumor research and drug development application progress and future prospectsSemantic proximity Read ↗

Application of CRISPR/Cas9 gene editing technique in the study of cancer treatmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.